Graft Patency and Clinical Outcomes Following Coronary Artery Bypass Grafting with Instrumented Radial Arteries

A/Prof Omar Farouque0 个研究点目标入组 294 人开始时间: 2021年3月10日最近更新: 2024年7月15日

适应症

试验速览

暂无简介。

•Whole study:
•Adult patients aged 18 years or older who underwent coronary artery bypass grafting between 2015-2019 using bilateral radial arteries as conduits.
•For the Patency arm of the study (Aim 1):
•Patients who underwent CABG with an instrumented radial artery.
•; Whole study:
•Adult patients aged 18 years or older who underwent coronary artery bypass grafting between 2015-2019 using bilateral radial arteries as conduits.
•For the Patency arm of the study (Aim 1):
•Patients who underwent CABG with an instrumented radial artery.

•Patency follow up (Aim 1)
•- Stage 4 or more chronic kidney disease.
•- Patients who have had either an invasive coronary angiogram or CT coronary angiogram following surgery.
•- The CABG operation record does not specify the location of each radial artery (ie which RA is grafted to which native vessel).
•- Allergy to contrast agent.
•- Unable to sufficiently control heart rate to perform scan or contraindication to metoprolol administration if required
•Clinical follow up (Aim 2)
•- Unable to provide consent; Patency follow up (Aim 1)
•- Stage 4 or more chronic kidney disease.
•- Patients who have had either an invasive coronary angiogram or CT coronary angiogram following surgery.
•- The CABG operation record does not specify the location of each radial artery (ie which RA is grafted to which native vessel).
•- Allergy to contrast agent.
•- Unable to sufficiently control heart rate to perform scan or contraindication to metoprolol administration if required
•Clinical follow up (Aim 2)
•- Unable to provide consent

发起方

A/Prof Omar Farouque